In the last few years, proteomics has dealt with emerging or
re-emerging pathogens, including neglected agents, in order
to provide support in taxonomic microbial classification,
invasion mechanisms, life cycle stage switching, antigen
variation, drug target and drug resistance discovery, and
infection epidemiology.